{"id":12075,"date":"2026-06-02T06:49:15","date_gmt":"2026-06-02T04:49:15","guid":{"rendered":"https:\/\/neurohirurgija.in.rs\/?page_id=12075"},"modified":"2026-07-11T23:21:53","modified_gmt":"2026-07-11T21:21:53","slug":"sphenoid-wing-meningioma","status":"publish","type":"page","link":"https:\/\/neurohirurgija.in.rs\/en\/sphenoid-wing-meningioma\/","title":{"rendered":"Sphenoid Wing Meningioma \u2014 Symptoms, Diagnosis, Treatment, and Prognosis"},"content":{"rendered":"\n<div style=\"line-height:1.35; margin:0 0 18px 0;\">\n  <div>\n    <span style=\"font-weight:600;\">Author:<\/span>\n    <a href=\"https:\/\/neurohirurgija.in.rs\/en\/cv-en\/\" \n       style=\"color:#004a80; font-weight:600; text-decoration:none;\"\n       onmouseover=\"this.style.textDecoration='underline';\"\n       onmouseout=\"this.style.textDecoration='none';\">\n       Dr. Zeljko Kojadinovic, MD, PhD\n    <\/a>\n    \u2014 Consultant Neurosurgeon\n  <\/div>\n\n  <div>\n    <span style=\"font-weight:600;\">Specialized Experience:<\/span>\n    30 years of clinical expertise in neurosurgery.\n  <\/div>\n\n  <div>\n    <span style=\"font-weight:600;\">Last medically reviewed:<\/span>\n    March 08, 2026\n  <\/div>\n<\/div>\n\n\n\n<div style=\"background:#fff7cc; border:1px solid #ffe08a; padding:12px; border-radius:8px; margin:16px 0;\"> \n  <div style=\"font-weight:700; color:#5a4b00; font-size:16px; margin-bottom:6px;\">\n    <h3 id=\"who-this-sphenoid-wing-meningioma-page-is-for\">Who This Sphenoid Wing Meningioma Page Is For<\/h3>\n  <\/div>\n\n  <p style=\"margin:0; color:#3b2f00; line-height:1.5;\">\n    This page is intended for patients in whom MRI or CT has revealed a <strong>sphenoid wing meningioma<\/strong>, a tumor arising from the meninges along the <strong>sphenoid ridge of the skull base<\/strong>, located behind the eye and beside the <strong>frontal and temporal lobes<\/strong>.\n  <\/p>\n\n  <p style=\"margin:10px 0 0; color:#3b2f00; line-height:1.5;\">\n    If surgery, stereotactic radiosurgery (such as Gamma Knife), radiotherapy, or long-term MRI monitoring has been proposed \u2014 or if specialists have offered different recommendations regarding the urgency or type of treatment \u2014 an individualized \n    <a href=\"https:\/\/neurohirurgija.in.rs\/en\/second-opinion-in-neurosurgery-trusted-insight\/\" target=\"_blank\" rel=\"noopener\" style=\"color:#005c99; text-decoration:underline;\">\n      neurosurgical second opinion\n    <\/a>\n    may help.   <\/p>\n<\/div>\n\n\n\n<div style=\"border: 1px solid #d6d6d6; border-radius: 12px; padding: 16px; margin: 18px 0 10px; background: #f7f7f7;\">\n  \n  <div style=\"font-weight: 700; margin-bottom: 12px;\">\n    When patients seek a second opinion for sphenoid wing meningioma\n  <\/div>\n\n  <div style=\"font-size: 0.98em; line-height: 1.55;\">\n    <div style=\"margin-bottom: 6px;\">\n      \u2022 MRI or CT shows a <strong>sphenoid wing meningioma<\/strong> and the best treatment strategy is unclear\n    <\/div>\n    <div style=\"margin-bottom: 6px;\">\n      \u2022 The tumor was discovered incidentally and opinions differ between <strong>MRI monitoring, surgery, or radiosurgery<\/strong>\n    <\/div>\n    <div style=\"margin-bottom: 6px;\">\n      \u2022 <strong>Visual disturbances, double vision, eye protrusion (proptosis), headaches, or seizures<\/strong> suggest compression of the <strong>optic nerve, orbit, cavernous sinus, or adjacent brain structures<\/strong>\n    <\/div>\n    <div style=\"margin-bottom: 6px;\">\n      \u2022 Surgery is recommended but the <strong>risks, expected extent of removal, or long-term prognosis<\/strong> are uncertain\n    <\/div>\n    <div style=\"margin-bottom: 6px;\">\n      \u2022 <strong>Radiosurgery or radiotherapy<\/strong> is proposed but the role of surgery remains unclear\n    <\/div>\n    <div>\n      \u2022 Specialists recommend <strong>different treatment strategies<\/strong> without clear agreement\n    <\/div>\n  <\/div>\n\n  <div style=\"margin-top: 12px; font-size: 0.98em; line-height: 1.45;\">\n    If your situation involves uncertainty regarding diagnosis, urgency, or treatment strategy, you may request an individualized neurosurgical review here:\n    <a href=\"#telehealth\" style=\"font-weight: 700; text-decoration: underline;\">\n      Request Second Opinion\n    <\/a>\n  <\/div>\n\n<\/div>\n\n\n\n<div style=\"background:#f4faff; border:1px solid #cce5ff; padding:14px 16px; border-radius:12px; margin:18px 0; box-shadow:0 10px 22px rgba(0,60,120,0.06);\"> \n  <h3 id=\"sphenoid-wing-meningioma-quick-summary\" style=\"margin:0 0 10px 0; color:#003a66; font-size:18px;\">\n    Sphenoid Wing Meningioma \u2014 Quick Summary (Read This First)\n  <\/h3>\n\n  <ul style=\"margin:0; padding-left:18px; color:#0f172a; line-height:1.55;\">\n\n    <li><strong>Sphenoid wing meningioma is a tumor arising from the meninges along the sphenoid ridge of the skull base.<\/strong> \n    It develops behind the eye and beside the frontal and temporal lobes.<\/li>\n\n    <li><strong>Sphenoid wing meningiomas grow outside the brain tissue.<\/strong> \n    They compress nearby brain structures without directly invading the brain.<\/li>\n\n    <li><strong>Sphenoid wing meningiomas account for approximately 15\u201320% of intracranial meningiomas.<\/strong> \n    They arise along the sphenoid ridge and may extend toward the orbit, optic canal, cavernous sinus, or skull base bone.<\/li>\n\n    <li><strong>Many sphenoid wing meningiomas grow slowly and may remain stable for years.<\/strong> \n    Some tumors discovered incidentally on MRI may not require immediate treatment and can instead be monitored with periodic imaging.<\/li>\n\n    <li><strong>Symptoms depend mainly on tumor location.<\/strong> \n    Lateral tumors often present with headaches or seizures, while medial tumors may cause visual disturbances, double vision, or eye protrusion (proptosis).<\/li>\n\n    <li><strong>Larger tumors may compress the frontal or temporal lobes, optic pathways, or cranial nerves.<\/strong> \n    This can lead to headaches, seizures, visual decline, double vision, facial sensory changes, or other neurological deficits.<\/li>\n\n    <li><strong>MRI with contrast is the most important diagnostic test.<\/strong> \n    It shows tumor size, its relationship to the frontal and temporal lobes, optic nerves, cavernous sinus, orbit, and major arteries, as well as the presence of surrounding brain edema.<\/li>\n\n    <li><strong>Not all sphenoid wing meningiomas require immediate treatment.<\/strong> \n    Small tumors without symptoms or growth may initially be monitored with periodic MRI examinations.<\/li>\n\n    <li><strong>Surgery is the main treatment for symptomatic or growing tumors.<\/strong> \n    The goal is safe tumor removal while protecting the optic nerves, cranial nerves, major arteries, and normal brain function.<\/li>\n\n    <li><strong>Stereotactic radiosurgery or fractionated radiotherapy may be used in selected cases.<\/strong> \nRadiation is often considered for small growing tumors, residual tumor after surgery, recurrent tumors, or when surgery carries higher risk. \nWhen the tumor lies very close to the <strong>optic nerve or optic chiasm<\/strong>, <strong>fractionated radiotherapy<\/strong> is usually preferred to reduce the risk of radiation injury to vision. In some cases where the tumor is densely adherent to the <strong>optic nerve<\/strong>, <strong>cavernous sinus<\/strong>, or major arteries, surgery may intentionally remove only part of the tumor to <strong>decompress the optic pathways<\/strong> and create safer conditions for subsequent <strong>radiosurgery or radiotherapy<\/strong> of the remaining tumor.\n<\/li>\n    <li><strong>Treatment decisions depend mainly on tumor size, growth rate, symptoms, brain edema, and the tumor\u2019s relationship to nearby arteries, optic pathways, and cranial nerves.<\/strong> \n    The safest strategy is usually individualized.<\/li>\n\n    <li><strong>Most sphenoid wing meningiomas are benign WHO Grade I tumors.<\/strong> \n    Approximately 80\u201385% belong to Grade I, about 10\u201315% are atypical (WHO Grade II), and roughly 1\u20133% are malignant (WHO Grade III). Higher-grade tumors have a greater risk of recurrence.<\/li>\n\n    <li><strong>Although many tumors are benign, large sphenoid wing meningiomas can still cause serious neurological problems.<\/strong> \n    This occurs because of progressive compression of the frontal or temporal lobes, optic pathways, orbit, cranial nerves, or major skull base arteries.<\/li>\n\n  <\/ul>\n<\/div>\n\n<p style=\"margin:8px 0 0 0; color:#334155; font-size:14px; line-height:1.5;\">\n  Most readers benefit from reviewing this Quick Summary together with the sections on <strong>Symptoms of Sphenoid Wing Meningioma<\/strong>, <strong>Diagnosis<\/strong>, <strong>Surgical Treatment<\/strong>, <strong>Radiation Therapy<\/strong>, and <strong>Treatment Decision-Making<\/strong>. Later sections provide more detailed explanations intended for patients seeking a deeper understanding before important treatment decisions are made.\n<\/p>\n\n\n\n<style>\n\/* ===== Sphenoid Wing Meningioma TOC (Blue Accordion) ===== *\/\n.ptns-toc-simple {\n  max-width: 420px;\n  margin: 0 0 22px 0;\n  font-family: system-ui, -apple-system, \"Segoe UI\", Roboto, Arial, sans-serif;\n}\n.ptns-toc-simple .card {\n  background: #f4faff;\n  border: 1px solid #cce5ff;\n  border-radius: 12px;\n  padding: 14px;\n  box-shadow: 0 10px 22px rgba(0,60,120,0.06);\n}\n.ptns-toc-simple summary {\n  list-style: none;\n  cursor: pointer;\n  display: flex;\n  align-items: center;\n  justify-content: space-between;\n}\n.ptns-toc-simple summary::-webkit-details-marker { display:none; }\n\n.ptns-toc-simple .title {\n  font-weight: 800;\n  font-size: 22px;\n  color: #003a66;\n  margin: 0;\n}\n\n.ptns-toc-simple summary::after {\n  content: \"\u25b8 Show\";\n  font-weight: 700;\n  color: #005c99;\n  border: 1px solid #cce5ff;\n  padding: 6px 10px;\n  border-radius: 6px;\n  font-size: 13px;\n}\n\n.ptns-toc-simple details[open] summary::after {\n  content: \"\u25be Hide\";\n}\n\n.ptns-toc-simple ul {\n  margin: 12px 0 0 0;\n  padding: 0;\n  list-style: none;\n}\n\n.ptns-toc-simple li {\n  position: relative;\n  padding-left: 26px;\n  margin: 10px 0;\n  font-size: 15px;\n}\n\n.ptns-toc-simple li::before {\n  content: \"\";\n  width: 7px;\n  height: 7px;\n  border-radius: 50%;\n  background: #005c99;\n  position: absolute;\n  left: 8px;\n  top: 8px;\n}\n\n.ptns-toc-simple .sub-item {\n  padding-left: 42px;\n}\n.ptns-toc-simple .sub-item::before {\n  left: 24px;\n}\n\n.ptns-toc-simple a {\n  color: #005c99;\n  text-decoration: none;\n  font-weight: 700;\n}\n.ptns-toc-simple a:hover {\n  text-decoration: underline;\n}\n<\/style>\n\n<div class=\"ptns-toc-simple\" aria-label=\"Table of contents\">\n  <div class=\"card\">\n    <details>\n      <summary>\n        <h3 id=\"contents\" class=\"title\">Contents<\/h3>\n      <\/summary>\n\n      <ul>\n        <li><a href=\"#who-this-sphenoid-wing-meningioma-page-is-for\">Who This Page<\/a><\/li>\n        <li><a href=\"#sphenoid-wing-meningioma-quick-summary\">Quick Summary<\/a><\/li>\n\n        <li style=\"margin-top:14px;\"><a href=\"#definition\">Definition<\/a><\/li>\n        <li><a href=\"#tumor-grades\">Tumor Grades<\/a><\/li>\n        <li><a href=\"#causes\">Tumor Causes<\/a><\/li>\n        <li><a href=\"#how-affect-brain\">How They Affect<\/a><\/li>\n        <li><a href=\"#symptoms\">Symptoms<\/a><\/li>\n        <li><a href=\"#diagnosis\">MRI Diagnosis<\/a><\/li>\n\n        <li style=\"margin-top:14px;\"><a href=\"#only-observation\">When Monitored<\/a><\/li>\n        <li><a href=\"#symptomatic-treatment\">Symptom Relief<\/a><\/li>\n        <li><a href=\"#visual-symptoms\">Visual Symptoms<\/a><\/li>\n\n        <li style=\"margin-top:14px;\"><a href=\"#surgical-treatment\">Surgical Treatment<\/a><\/li>\n        <li><a href=\"#modern-surgical-technologies\">Modern Technologies<\/a><\/li>\n        <li><a href=\"#extent-of-tumor-removal\">Extent of Removal<\/a><\/li>\n        <li><a href=\"#radiation-therapy\">Radiation Therapy<\/a><\/li>\n        <li><a href=\"#telehealth\">Request Second Opinion<\/a><\/li>\n\n        <li style=\"margin-top:14px;\"><a href=\"#recurrence\">Recurrence<\/a><\/li>\n        \n\n        <li style=\"margin-top:14px;\"><a href=\"#treatment-decision-summary\">Treatment Summary<\/a><\/li>\n        \n\n        <li style=\"margin-top:14px;\"><a href=\"#experimental-therapy\">Experimental Therapies<\/a><\/li>\n        <li><a href=\"#when-opinions-differ\">Why Opinions Differ<\/a><\/li>\n       \n        <li style=\"margin-top:14px;\"><a href=\"#prognosis\">Overall Prognosis<\/a><\/li>\n        <li><a href=\"#can-this-tumor-be-dangerous\">Dangerous Tumor Risk<\/a><\/li>\n        <li><a href=\"#faq-sphenoid-wing-meningioma\">FAQ<\/a><\/li>\n      <\/ul>\n\n    <\/details>\n  <\/div>\n<\/div>\n\n<style>\nh2, h3 { scroll-margin-top:110px; }\n<\/style>\n\n\n\n<h2 id=\"definition\" class=\"wp-block-heading\">What Is a Sphenoid Wing Meningioma<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">A <strong>sphenoid wing meningioma<\/strong> is a meningioma that arises from the <strong>meninges<\/strong> along the <strong>sphenoid ridge<\/strong>, a bony structure of the <strong>skull base<\/strong> located behind the <strong>eye socket<\/strong> and extending beneath the <strong>frontal<\/strong> and <strong>temporal lobes<\/strong>. The term <strong>sphenoid ridge meningioma<\/strong> is also often used in clinical practice and radiology.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Most <a href=\"https:\/\/neurohirurgija.in.rs\/en\/meningiomas\/\">meningiomas<\/a> arise from specialized cells within the <strong>arachnoid layer<\/strong>, often called <strong>arachnoid cap cells<\/strong>. When genetic changes occur in these cells, they may begin to multiply abnormally and gradually form a tumor. Unlike tumors that originate inside the brain tissue, sphenoid wing meningiomas grow <strong>outside the brain<\/strong>, attached to the <strong>dura mater<\/strong> of the skull base. As they enlarge, they typically <strong>compress the surrounding brain without directly invading the brain tissue<\/strong>.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Because of this growth pattern, they often remain <strong>well-defined masses<\/strong>, are often in close contact with nearby arteries, the optic nerve, cavernous sinus structures, or the orbit, <strong>compress them<\/strong>, and in some cases become <strong>firmly adherent<\/strong> to these structures. The skull base bone at the site of tumor origin is often <strong>thickened (hyperostosis)<\/strong>, reflecting tumor involvement of the underlying bone.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Sphenoid wing meningiomas represent approximately 15\u201320% of intracranial meningiomas.<\/strong> Because of their location near the <strong>skull base<\/strong>, <strong>orbit<\/strong>, and <strong>optic pathways<\/strong>, they may produce important symptoms even when they are not very large.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Meningiomas occur approximately <strong>two to three times more frequently in women<\/strong> than in men. They are also <strong>rare in children<\/strong>, representing <strong>less than 2% of all pediatric brain tumors<\/strong>.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">A useful practical division of these tumors is the following:<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">\u2022 <strong>Lateral sphenoid wing meningiomas<\/strong> \u2014 usually more similar to <strong>convexity meningiomas<\/strong> in surgical behavior<br>\u2022 <strong>Middle sphenoid wing meningiomas<\/strong> \u2014 intermediate lesions with variable extension<br>\u2022 <strong>Medial sphenoid wing meningiomas<\/strong> \u2014 more complex skull base tumors often close to the <strong>optic nerve<\/strong> (the nerve for vision), <strong>carotid artery<\/strong> (the main artery supplying the brain), <strong>cavernous sinus<\/strong> (a critical area containing nerves and vessels), and <strong>orbital apex<\/strong> (the narrow opening at the back of the eye socket).<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">In many patients, the tumor grows slowly and initially produces few symptoms. <strong>Lateral sphenoid wing meningiomas may resemble convexity meningiomas in their behavior and surgical accessibility<\/strong>, often presenting with <strong>headaches<\/strong> or <strong>seizures<\/strong> due to compression of the adjacent frontal or temporal lobe. By contrast, <strong>medial sphenoid wing meningiomas<\/strong> are usually more complex because they may extend toward the <strong>optic canal<\/strong>, <strong>cavernous sinus<\/strong>, <strong>carotid artery<\/strong>, <strong>orbital apex<\/strong>, or <strong>cranial nerves<\/strong>. As the tumor grows further, patients may develop <strong>headaches<\/strong>, <strong>visual decline<\/strong>, <strong>double vision<\/strong>, <strong>eye protrusion<\/strong>, <strong>seizures<\/strong>, or other neurological deficits depending on the exact direction of growth.<\/p>\n\n\n\n<figure class=\"wp-block-image size-full is-resized\"><img loading=\"lazy\" decoding=\"async\" width=\"748\" height=\"608\" src=\"https:\/\/neurohirurgija.in.rs\/wp-content\/uploads\/2026\/03\/Sphenoid-meningeoma-anatomy.jpg\" alt=\"View of a medial sphenoid wing tumor between the retracted frontal and temporal lobes. The tumor is seen compressing the optic nerve and the carotid artery, as well as the cavernous sinus, which already contains the nerves responsible for eye movement and facial sensation.\" class=\"wp-image-12101\" style=\"width:436px;height:auto\" srcset=\"https:\/\/neurohirurgija.in.rs\/wp-content\/uploads\/2026\/03\/Sphenoid-meningeoma-anatomy.jpg 748w, https:\/\/neurohirurgija.in.rs\/wp-content\/uploads\/2026\/03\/Sphenoid-meningeoma-anatomy-300x244.jpg 300w, https:\/\/neurohirurgija.in.rs\/wp-content\/uploads\/2026\/03\/Sphenoid-meningeoma-anatomy-15x12.jpg 15w\" sizes=\"auto, (max-width: 748px) 100vw, 748px\" \/><\/figure>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Image: View of a medial sphenoid wing tumor between the retracted frontal and temporal brain lobes. The tumor is seen compressing the optic nerve and the carotid artery, as well as the cavernous sinus, which already contains the nerves responsible for eye movement and facial sensation.<\/strong><\/p>\n\n\n\n<figure class=\"wp-block-image size-full is-resized\"><img loading=\"lazy\" decoding=\"async\" width=\"960\" height=\"540\" src=\"https:\/\/neurohirurgija.in.rs\/wp-content\/uploads\/2026\/03\/Miningioma-location-1.jpg\" alt=\"Sphenoid wing meningiomas and meningiomas of other locations\" class=\"wp-image-12080\" style=\"aspect-ratio:1.7777488425925927;width:829px;height:auto\" srcset=\"https:\/\/neurohirurgija.in.rs\/wp-content\/uploads\/2026\/03\/Miningioma-location-1.jpg 960w, https:\/\/neurohirurgija.in.rs\/wp-content\/uploads\/2026\/03\/Miningioma-location-1-300x169.jpg 300w, https:\/\/neurohirurgija.in.rs\/wp-content\/uploads\/2026\/03\/Miningioma-location-1-768x432.jpg 768w, https:\/\/neurohirurgija.in.rs\/wp-content\/uploads\/2026\/03\/Miningioma-location-1-18x10.jpg 18w\" sizes=\"auto, (max-width: 960px) 100vw, 960px\" \/><\/figure>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Image: Sphenoid wing meningiomas and meningiomas of other locations<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">You can read more about other brain tumors on our&nbsp;<a href=\"https:\/\/neurohirurgija.in.rs\/en\/brain-tumors\/\">Brain Tumors<\/a>&nbsp;page.<\/p>\n\n\n\n<h2 id=\"tumor-grades\" class=\"wp-block-heading\">Biological Classification of Meningiomas<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">The biological behavior of sphenoid wing meningiomas is determined through <strong>histopathological analysis<\/strong> using the <strong>World Health Organization (WHO) classification<\/strong>.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Three main categories are recognized:<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">\u2022 <strong>WHO grade I \u2014 benign meningioma.<\/strong> This is the most common form, representing roughly <strong>80\u201385%<\/strong> of meningiomas. These tumors typically grow slowly and often remain stable for long periods. When completely removed surgically, the chance of recurrence is relatively low.<br>\u2022 <strong>WHO grade II \u2014 atypical meningioma.<\/strong> Atypical meningiomas account for approximately <strong>10\u201315%<\/strong> of cases in surgical series. These tumors show increased cellular activity and a higher likelihood of recurrence after surgery. After complete tumor removal, some patients may be managed with MRI follow-up rather than immediate radiation therapy.<br>\u2022 <strong>WHO grade III \u2014 malignant (anaplastic) meningioma.<\/strong> These tumors are rare, representing roughly <strong>1\u20133%<\/strong> of cases. They grow more aggressively, recur more frequently, and usually require combined treatment with surgery and radiation therapy.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Although histological grade is important, clinical outcome also depends strongly on <strong>tumor location<\/strong>, the relationship to the <strong>optic nerve<\/strong>, <strong>carotid artery<\/strong>, <strong>cavernous sinus<\/strong>, <strong>orbit<\/strong>, <strong>frontal and temporal lobes<\/strong>, and the possibility of <strong>complete surgical removal<\/strong>.<\/p>\n\n\n\n<h2 id=\"causes\" class=\"wp-block-heading\">Genetic and Biological Causes<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Most sphenoid wing meningiomas arise from <strong>sporadic genetic mutations<\/strong> that occur during life rather than inherited genetic disorders. At the molecular level, tumor development usually results from two main biological mechanisms:<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">\u2022 <strong>inactivation of tumor suppressor genes<\/strong>, which normally prevent uncontrolled cell growth<br>\u2022 <strong>activation of oncogenic signaling pathways<\/strong>, which stimulate cell proliferation<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The most frequently involved gene is <strong>NF2<\/strong>, located on chromosome 22. Loss of function of this gene disrupts normal cell growth control and allows tumor formation. Other molecular alterations identified in meningiomas include mutations involving genes such as <strong>TRAF7<\/strong>, <strong>AKT1<\/strong>, <strong>SMO<\/strong>, and <strong>KLF4<\/strong>, while additional less common alterations may involve genes such as <strong>PIK3CA<\/strong> or <strong>TERT<\/strong>.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The only clearly established environmental risk factor is exposure to <strong>ionizing radiation<\/strong>, particularly during childhood.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Meningiomas occur approximately <strong>two to three times more frequently in women<\/strong> than in men, suggesting that <strong>hormonal influences<\/strong> may play a role in tumor development and growth.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Although most meningiomas arise sporadically, a small proportion occur in the context of inherited genetic syndromes. The best known example is <strong>neurofibromatosis type 2 (NF2)<\/strong>. Patients with NF2 may develop <strong>multiple meningiomas<\/strong> in different intracranial and spinal locations.<\/p>\n\n\n\n<h2 id=\"how-affect-brain\" class=\"wp-block-heading\">How Sphenoid Wing Meningiomas Grow and Affect the Brain<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Sphenoid wing meningiomas usually grow <strong>slowly over many years<\/strong>. Because they arise <strong>outside the brain tissue<\/strong>, they affect the brain mainly through <strong>compression<\/strong> and do not infiltrate the brain.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">In <strong>lateral tumors<\/strong>, growth may mainly compress the adjacent <a href=\"https:\/\/neurohirurgija.in.rs\/en\/brain-anatomy-simply-explained\/\"><strong>frontal<\/strong> or <strong>temporal lobe<\/strong><\/a> (parts of the brain responsible for personality and memory). In more <strong>medial tumors<\/strong>, the lesion may gradually extend toward the <strong><a href=\"https:\/\/neurohirurgija.in.rs\/en\/cranial-nerves-simply-explained\/\">optic nerve<\/a><\/strong> (nerve for vision), <strong>optic canal<\/strong> (the bony tunnel for the eye nerve), <strong>cavernous sinus<\/strong> (a critical area containing nerves and blood vessels), <strong>superior orbital fissure<\/strong> (the opening for nerves that move the eye), <strong>orbital apex<\/strong> (the back of the eye socket), or <strong>internal carotid artery<\/strong> (the main artery supplying the brain).<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Studies following patients with untreated meningiomas have shown that a substantial proportion of tumors remain <strong>stable for long periods<\/strong>. Among tumors that do grow, the increase in size is usually <strong>slow and gradual<\/strong>, often measured in <strong>millimeters per year<\/strong> rather than rapid expansion.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Another important mechanism is <strong><a href=\"https:\/\/neurohirurgija.in.rs\/en\/brain-edema-explained\/\">peritumoral brain edema<\/a><\/strong>, a form of swelling in the surrounding brain tissue caused by leakage of fluid from nearby blood vessels. This swelling increases <strong><a href=\"https:\/\/neurohirurgija.in.rs\/en\/intracranial-pressure-icp-explained\/\">intracranial pressure<\/a><\/strong> and often worsens symptoms.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Together with the enlarged tumor itself, this edema can produce a <a href=\"https:\/\/neurohirurgija.in.rs\/en\/mass-effect-midline-shift-brain-herniation-explained\/\"><strong>mass effect<\/strong>,<\/a> meaning that the expanding lesion compresses and displaces normal brain structures. Because the skull is a rigid, closed cavity with limited space for expansion, increasing pressure may eventually force parts of the brain to shift from their normal position. In severe cases, this may lead to <strong>brain herniation<\/strong>, which is a dangerous stage of mass effect.<\/p>\n\n\n\n<h2 id=\"symptoms\" class=\"wp-block-heading\">Symptoms of Sphenoid Wing Meningioma<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">The symptoms caused by sphenoid wing meningiomas depend mainly on <strong>tumor size<\/strong>, <strong>surrounding edema<\/strong>, and involvement of <strong>nearby structures<\/strong>.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Typical symptoms may include:<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">\u2022 <strong>headaches<\/strong>, especially when the tumor becomes larger<br>\u2022 <strong><a href=\"https:\/\/neurohirurgija.in.rs\/en\/epilepsy-surgery-when-it-is-the-right-option\/\">seizures<\/a><\/strong>, particularly in tumors irritating the adjacent temporal or frontal lobe<br>\u2022 <strong>visual disturbances<\/strong>, especially in medial tumors compressing the <strong>optic nerve<\/strong> or <strong>optic canal<\/strong><br>\u2022 <strong>double vision<\/strong> or <strong>eye movement abnormalities<\/strong> when cranial nerves in the <strong>cavernous sinus<\/strong> or <strong>superior orbital fissure<\/strong> are affected<br>\u2022 <strong>eye protrusion (proptosis)<\/strong>, especially when the tumor extends into the <strong>orbit<\/strong> or causes marked <strong>hyperostosis<\/strong> of the sphenoid bone. Family members sometimes notice progressive <strong>eye prominence<\/strong> before the patient seeks evaluation.<br>\u2022 <strong>facial numbness or pain<\/strong> in selected cases involving nearby trigeminal pathways<br>\u2022 <strong>cognitive slowing<\/strong> or <strong>behavioral change<\/strong> if there is significant frontal lobe compression and brain swelling<br>\u2022 <strong>progressive neurological deficits<\/strong> in advanced tumors involving critical skull base structures<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Because symptoms develop gradually, some patients are first evaluated for <strong>visual decline<\/strong>, <strong>orbital asymmetry<\/strong>, <strong>chronic headaches<\/strong>, or <strong>seizures<\/strong> before the tumor is discovered on imaging.<\/p>\n\n\n\n<h2 id=\"diagnosis\" class=\"wp-block-heading\">Diagnosis of Sphenoid Wing Meningioma<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">The most important diagnostic test is <strong>MRI of the brain with contrast<\/strong>.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">During this examination, the patient lies inside the MRI scanner while magnetic fields generate highly detailed images of the brain. A contrast agent injected through a vein highlights tumor tissue.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">MRI allows physicians to determine:<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">\u2022 <strong>tumor size<\/strong><br>\u2022 <strong>precise location<\/strong> along the sphenoid wing<br>\u2022 relationship to the <strong>frontal and temporal lobes<\/strong><br>\u2022 relationship to the <strong>optic nerve<\/strong>, <strong>optic canal<\/strong>, <strong>orbit<\/strong>, <strong>cavernous sinus<\/strong>, and <strong>carotid artery<\/strong><br>\u2022 presence of <strong>surrounding brain edema<\/strong><br>\u2022 possible extension into the optic canal, <strong>orbit<\/strong> or <strong>skull base bone<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Sphenoid wing meningiomas typically appear as <strong>well-defined extra-axial tumors<\/strong> attached to the dura of the sphenoid ridge, often with <strong>strong contrast enhancement<\/strong> and sometimes with a <strong>dural tail<\/strong>.<\/p>\n\n\n\n<figure class=\"wp-block-image size-full is-resized\"><img loading=\"lazy\" decoding=\"async\" width=\"797\" height=\"483\" src=\"https:\/\/neurohirurgija.in.rs\/wp-content\/uploads\/2026\/03\/Sphenoid-wing-meningioma-MRI-1.jpg\" alt=\"\" class=\"wp-image-12086\" style=\"width:915px;height:auto\" srcset=\"https:\/\/neurohirurgija.in.rs\/wp-content\/uploads\/2026\/03\/Sphenoid-wing-meningioma-MRI-1.jpg 797w, https:\/\/neurohirurgija.in.rs\/wp-content\/uploads\/2026\/03\/Sphenoid-wing-meningioma-MRI-1-300x182.jpg 300w, https:\/\/neurohirurgija.in.rs\/wp-content\/uploads\/2026\/03\/Sphenoid-wing-meningioma-MRI-1-768x465.jpg 768w, https:\/\/neurohirurgija.in.rs\/wp-content\/uploads\/2026\/03\/Sphenoid-wing-meningioma-MRI-1-18x12.jpg 18w\" sizes=\"auto, (max-width: 797px) 100vw, 797px\" \/><\/figure>\n\n\n\n<p class=\"wp-block-paragraph\"><br><strong>Image: (a) Preoperative MRI scan (T1 with contrast) showing a large tumor; (b) Postoperative scan after partial surgical removal and follow-up radiation therapy, showing the remaining tumor is under control. <\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The final diagnosis is confirmed through <strong>histopathological analysis<\/strong> after surgery or biopsy.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">However, several other conditions may occasionally produce similar imaging findings and should be considered in the differential diagnosis.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">These include:<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">\u2022 other <strong>skull base meningiomas<\/strong><br>\u2022 <strong>dural metastases<\/strong><br>\u2022 <strong>solitary fibrous tumor \/ hemangiopericytoma<\/strong><br>\u2022 <strong>schwannoma<\/strong> in selected skull base locations<br>\u2022 <strong>orbital or skull base tumors<\/strong> with intracranial extension<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Although MRI is the main imaging method used to diagnose sphenoid wing meningiomas, <strong>CT scans<\/strong> may provide useful additional information. CT is particularly helpful in evaluating <strong>hyperostosis<\/strong>, <strong>skull base bone changes<\/strong>, <strong>calcification<\/strong>, <strong>orbital involvement<\/strong>, and <strong>narrowing of the optic canal<\/strong>. In selected cases, <strong>vascular imaging<\/strong> may also be required to assess the relationship of the tumor to the <strong>internal carotid artery<\/strong> or <strong>middle cerebral vessels<\/strong>.<\/p>\n\n\n\n<h2 id=\"only-observation\" class=\"wp-block-heading\">Monitoring Without Treatment: When a Sphenoid Wing Meningioma Is Only Observed<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Not all sphenoid wing meningiomas require immediate treatment.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Observation may be considered when:<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">\u2022 the tumor is <strong>small<\/strong><br>\u2022 the patient has <strong>no clear neurological symptoms<\/strong><br>\u2022 imaging shows <strong>little or no growth<\/strong> over time<br>\u2022 there is <strong>little or no surrounding edema<\/strong><br>\u2022 there is <strong>no significant compression<\/strong> of the optic pathways, orbit, or brain<br>\u2022 the patient is <strong>elderly<\/strong> or has serious medical conditions increasing surgical risk<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Follow-up generally involves <strong>MRI examinations every 6\u201312 months initially<\/strong>. If a small tumor shows documented growth and remains at a safe distance from the optic pathways and other critical structures, treatment may in selected cases be performed with <strong>stereotactic radiosurgery (SRS)<\/strong> rather than surgery.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">However, observation must be <strong>individualized carefully<\/strong> in this location. Even slowly growing bigger tumors may eventually threaten <strong>vision<\/strong>, <strong>cranial nerve function<\/strong>, or the <strong>orbit<\/strong>, and some patients do not notice gradual deterioration until the tumor becomes more complex. For this reason, the decision to observe rather than treat depends not only on tumor size, but also on growth trend, edema, visual risk, anatomical extension, and the overall clinical context. <strong>In some patients, even if the tumor size remains stable on MRI, progressive visual decline may indicate compression of the optic nerve \u2014 particularly when the tumor extends into the optic canal. In such cases, surgical decompression of the optic nerve may be recommended even without clear radiological tumor growth.<\/strong><\/p>\n\n\n\n<h2 id=\"symptomatic-treatment\" class=\"wp-block-heading\">Symptomatic Treatment<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Medications are often used to control complications caused by the tumor.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">\u2022 <strong>Brain swelling (edema)<\/strong> is commonly treated with <strong>corticosteroids<\/strong>, most often <strong>dexamethasone<\/strong>, which reduces edema in the surrounding brain tissue.<br>\u2022 <strong><a href=\"https:\/\/neurohirurgija.in.rs\/en\/seizures-after-brain-injury\/\">Seizures<\/a><\/strong> are treated with <strong>antiepileptic medications<\/strong>, such as <strong>levetiracetam<\/strong> or other modern antiseizure drugs.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">These medications may stabilize the patient temporarily but <strong>do not eliminate the tumor itself<\/strong>.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong><a href=\"https:\/\/neurohirurgija.in.rs\/en\/headache-when-to-worry\/\">Headache <\/a>is common<\/strong>, particularly in larger tumors associated with significant edema or raised intracranial pressure. Headache in patients with small meningiomas does not necessarily mean that the tumor is the cause. Many patients have common primary headache disorders such as <strong>tension-type headache<\/strong>, <strong>migraine<\/strong>, or <strong>cervicogenic headache<\/strong>, which are frequent in the general population and may occur independently of the tumor. For this reason, the type of headache should be carefully evaluated before attributing the symptoms to the meningioma, and <strong>the presence of headache alone is usually not a sufficient reason to recommend immediate surgical removal of a small, otherwise asymptomatic tumor.<\/strong><\/p>\n\n\n\n<h2 id=\"surgical-treatment\" class=\"wp-block-heading\">Surgical Treatment of Sphenoid Wing Meningiomas<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Surgery remains the <strong>primary treatment<\/strong> for <strong>symptomatic<\/strong> or <strong>progressively growing sphenoid wing meningiomas<\/strong>. The procedure is usually performed through a <strong><a href=\"https:\/\/neurohirurgija.in.rs\/en\/craniotomy-explained\/\">craniotomy<\/a><\/strong>, which involves temporarily removing a portion of the skull to access the tumor.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">In most cases the operation proceeds through several stages:<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">\u2022 <strong>Skin incision and craniotomy<\/strong><br><strong>The scalp is opened using a carefully planned incision<\/strong>, usually placed within the <strong>hair-bearing area<\/strong> for cosmetic reasons. The standard approach for many <strong>sphenoid wing meningiomas<\/strong> is a <strong>pterional (frontotemporal) craniotomy<\/strong>, which provides direct access to the <strong>sphenoid ridge<\/strong> and adjacent <strong>skull base structures<\/strong>. In selected <strong>medial tumors<\/strong> or <strong>spheno-orbital meningiomas<\/strong>, the surgical exposure may need to be <strong>extended or modified<\/strong> depending on the tumor\u2019s <strong>anatomical extension<\/strong>, <strong>optic canal involvement<\/strong>, proximity to the <strong>cavernous sinus<\/strong>, <strong>orbital invasion<\/strong>, and the <strong>surgeon\u2019s preference<\/strong>.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">\u2022 <strong>Opening of the dura<\/strong><br>The dura mater is carefully opened to expose the tumor and surrounding brain and skull base structures.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">\u2022 <strong>Internal tumor debulking<\/strong><br>Whenever possible, the surgeon first attempts to control or detach the tumor from its dural attachment to reduce bleeding, because meningiomas receive much of their blood supply from dural vessels. The tumor is then reduced from the inside, most often using an <strong>ultrasonic aspirator (CUSA)<\/strong>. This internal debulking decreases tumor volume and pressure, making subsequent dissection safer.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">\u2022 <strong>Microsurgical dissection<\/strong><br>The remaining peripheral parts of the tumor are then gradually separated from the surrounding brain tissue, blood vessels, cranial nerves, optic apparatus, and orbital structures when involved. These residual portions of the tumor are removed piece by piece under <strong>microsurgical visualization<\/strong> (under the neurosurgical microscope)<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">\u2022 <strong>Treatment of the dural attachment<\/strong><br>Because the tumor arises from the dura of the sphenoid wing, the involved dura is usually <strong>removed or coagulated whenever possible<\/strong> to reduce recurrence risk.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">\u2022 <strong>Removal of infiltrated bone when present<\/strong><br>Some sphenoid wing meningiomas produce <strong>hyperostosis<\/strong> or infiltration of the sphenoid bone. In such cases, abnormal bone may need to be <strong>drilled away<\/strong>, and in selected situations <strong>decompression of the optic nerve<\/strong> by opening the bony optic canal or <strong>orbital reconstruction<\/strong> may be required.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">\u2022 <strong>Dural reconstruction and closure<\/strong><br>After tumor removal, the dura is reconstructed if necessary. The bone flap is replaced, and the scalp is closed.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The main goals of surgery are:<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">\u2022 <strong>safe tumor removal<\/strong><br>\u2022 <strong>decompression of the brain, optic pathways, and orbit<\/strong> when involved<br>\u2022 <strong>protection of the carotid artery, cranial nerves, and major vessels<\/strong><br>\u2022 <strong>reduction of recurrence risk<\/strong><br>\u2022 <strong>preservation of neurological and visual function<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Lateral sphenoid wing meningiomas are often more surgically similar to convexity meningiomas and may allow more complete removal.<\/strong><br><strong>By contrast, medial sphenoid wing meningiomas are often technically more demanding<\/strong> because of their close relationship to the <strong>optic nerve<\/strong>, <strong>carotid artery<\/strong>, <strong>cavernous sinus<\/strong>, <strong>orbital apex<\/strong>, and <strong>cranial nerves<\/strong>.<\/p>\n\n\n\n<figure class=\"wp-block-image size-full\"><img loading=\"lazy\" decoding=\"async\" width=\"898\" height=\"292\" src=\"https:\/\/neurohirurgija.in.rs\/wp-content\/uploads\/2026\/03\/pterional-craniotomies.jpg\" alt=\"Various types of pterional craniotomies  can be used for sphenoid wing meningioma surgery, depending on the tumor\u2019s size, its dominant growth direction, or the surgeon\u2019s preference.\" class=\"wp-image-12083\" srcset=\"https:\/\/neurohirurgija.in.rs\/wp-content\/uploads\/2026\/03\/pterional-craniotomies.jpg 898w, https:\/\/neurohirurgija.in.rs\/wp-content\/uploads\/2026\/03\/pterional-craniotomies-300x98.jpg 300w, https:\/\/neurohirurgija.in.rs\/wp-content\/uploads\/2026\/03\/pterional-craniotomies-768x250.jpg 768w, https:\/\/neurohirurgija.in.rs\/wp-content\/uploads\/2026\/03\/pterional-craniotomies-18x6.jpg 18w\" sizes=\"auto, (max-width: 898px) 100vw, 898px\" \/><\/figure>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Image: Various types of pterional craniotomies  can be used for sphenoid wing meningioma surgery, depending on the tumor\u2019s size, its dominant growth direction, or the surgeon\u2019s preference.<\/strong><br><\/p>\n\n\n\n<figure class=\"wp-block-image size-large is-resized\"><img decoding=\"async\" src=\"https:\/\/neurohirurgija.in.rs\/wp-content\/uploads\/2026\/01\/Craniotomy2.jpg\" alt=\"The image illustrates a craniotomy. Both the skin incision and the skull opening are performed within the hair-bearing area of the scalp. The dura is opened to expose the brain as part of the surgical approach to the tumor. After the procedure, the bone flap is secured and the scalp is reconstructed, ensuring no cosmetic defect remains after healing. The same principles apply to the pterional craniotomies shown in the image above regarding sphenoid wing meningioma surgery.\" style=\"aspect-ratio:1.4084731774415407;width:541px;height:auto\"\/><\/figure>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Image: The image illustrates a craniotomy. Both the skin incision and the skull opening are performed within the hair-bearing area of the scalp. The dura is opened to expose the brain as part of the surgical approach to the tumor. After the procedure, the bone flap is secured and the scalp is reconstructed, ensuring no cosmetic defect remains after healing. The same principles apply to the pterional craniotomies shown in the image above regarding sphenoid wing meningioma surgery.<\/strong><\/p>\n\n\n\n<figure class=\"wp-block-image size-full is-resized\"><img loading=\"lazy\" decoding=\"async\" width=\"548\" height=\"582\" src=\"https:\/\/neurohirurgija.in.rs\/wp-content\/uploads\/2026\/03\/meningioma-removal-4.jpg\" alt=\"\" class=\"wp-image-12082\" style=\"aspect-ratio:0.9415791875855773;width:349px;height:auto\" srcset=\"https:\/\/neurohirurgija.in.rs\/wp-content\/uploads\/2026\/03\/meningioma-removal-4.jpg 548w, https:\/\/neurohirurgija.in.rs\/wp-content\/uploads\/2026\/03\/meningioma-removal-4-282x300.jpg 282w, https:\/\/neurohirurgija.in.rs\/wp-content\/uploads\/2026\/03\/meningioma-removal-4-11x12.jpg 11w\" sizes=\"auto, (max-width: 548px) 100vw, 548px\" \/><\/figure>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Image: Stages of surgical removal of a meningioma. After craniotomy and opening of the dura, image (a) shows the dark brown meningioma. Image (b) illustrates its separation from the brain, blood vessels, and other normal tissues, followed by its piecemeal reduction. Image (c) shows the removal of the remaining peripheral parts of the meningioma. Image (d) shows the condition after the meningioma has been completely removed.<br> These same surgical principles are also applied in the surgery of sphenoid wing meningiomas.<\/strong><\/p>\n\n\n\n<h2 id=\"modern-surgical-technologies\" class=\"wp-block-heading\">Modern Surgical Technologies<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Modern neurosurgery employs several technologies to increase <strong>precision<\/strong> and <strong>safety<\/strong>.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">\u2022 <strong>Neuronavigation systems<\/strong> function as intraoperative GPS, allowing the surgeon to navigate within the skull with millimeter accuracy<br>\u2022 <strong>Ultrasonic aspirators (CUSA)<\/strong> fragment and aspirate tumor tissue while preserving surrounding blood vessels and nerves<br>\u2022 <strong>Intraoperative neurophysiological monitoring<\/strong> may be used in selected cases, depending on tumor extension and nearby critical structures<br>\u2022 <strong>Microsurgical magnification<\/strong> allows careful dissection from arteries, optic pathways, cranial nerves, and skull base surfaces<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">These technologies significantly improve precision and reduce risk during surgery.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">In selected cases, <strong>preoperative embolization<\/strong> may be considered, but this is less common and depends on the vascular supply of the tumor.<\/p>\n\n\n\n<h2 id=\"extent-of-tumor-removal\" class=\"wp-block-heading\">Extent of Tumor Removal \u2014 Simpson Classification<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">The completeness of tumor removal is classified using the <strong>Simpson grading system<\/strong>.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">\u2022 <strong>Simpson Grade I<\/strong> \u2014 complete removal of the tumor and its dural attachment<br>\u2013 recurrence risk approximately <strong>5\u201310%<\/strong> over long-term follow-up<br>\u2013 probability of needing another intervention <strong>~3\u20135%<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">\u2022 <strong>Simpson Grade II<\/strong> \u2014 tumor removed, dural attachment coagulated<br>\u2013 recurrence risk approximately <strong>10\u201320%<\/strong><br>\u2013 probability of further treatment <strong>~5\u201310%<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">\u2022 <strong>Simpson Grade III<\/strong> \u2014 tumor removed but dura left intact<br>\u2013 recurrence risk approximately <strong>20\u201330%<\/strong><br>\u2013 probability of additional treatment <strong>~10\u201320%<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">\u2022 <strong>Simpson Grade IV<\/strong> \u2014 subtotal removal<br>\u2013 recurrence risk approximately <strong>40\u201360%<\/strong><br>\u2013 additional treatment often required in <strong>30\u201350%<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">\u2022 <strong>Simpson Grade V<\/strong> \u2014 biopsy or decompression only<br>\u2013 tumor progression expected in most patients<br>\u2013 further definitive treatment usually necessary<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">In sphenoid wing meningiomas, the extent of removal may be influenced by the relationship of the tumor to the <strong>optic nerve<\/strong>, <strong>carotid artery<\/strong>, <strong>cavernous sinus<\/strong>, <strong>orbit<\/strong>, <strong>cranial nerves<\/strong>, and infiltrated <strong>skull base bone<\/strong>.<\/p>\n\n\n\n<h2 id=\"radiation-therapy\" class=\"wp-block-heading\">Radiation Therapy for Sphenoid Wing Meningiomas<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Radiation therapy is used when <strong>complete surgical removal is not possible<\/strong>, when tumors <strong>recur<\/strong>, or when a <strong>small residual tumor<\/strong> remains after surgery. It may also be considered for <strong>small tumors<\/strong> that demonstrate clear growth during imaging follow-up, particularly when surgery carries increased risk.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Typical radiation doses for meningiomas are:<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">\u2022 <strong>12\u201316 Gy<\/strong> delivered in a single session in <strong>stereotactic radiosurgery (SRS)<\/strong>, typically used for small sphenoid wing meningiomas, usually smaller than about <strong>2.5\u20133 cm<\/strong> in diameter, especially when the tumor does not produce significant brain compression and is located at a safe distance from the optic apparatus. It is also commonly used for <strong>small residual tumors after surgery<\/strong>.<br>\u2022 <strong>50\u201354 Gy in fractionated radiotherapy<\/strong>, delivered over several weeks. This approach is often considered when surgery is not possible or when radiosurgery is unsuitable due to tumor size or proximity to the <strong>optic nerve<\/strong>, <strong>optic chiasm<\/strong>, or other critical structures. <strong>It may also be used for tumors that continue to grow or compress the optic nerve when surgical removal is not feasible or carries excessive risk.<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Radiation therapy can effectively stop tumor growth in many patients. Modern radiation techniques provide <strong>long-term tumor control in approximately 85\u201395% of benign meningiomas<\/strong>, especially when small tumors are treated with stereotactic radiosurgery.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Sometimes even relatively small tumors may be unsuitable for <strong>single-session radiosurgery<\/strong> if they lie very close to the <strong>optic nerve<\/strong> or <strong>cavernous sinus structures<\/strong>, because these tissues tolerate only limited radiation exposure. In tumors located close to the optic pathways, <strong>fractionated radiation<\/strong> is often preferred over single-session radiosurgery because it may reduce the risk of <strong>radiation injury to vision<\/strong>.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">In some patients with <strong>small residual tumor<\/strong> near the <strong>optic pathways<\/strong>, <strong>carotid artery<\/strong>, or <strong>cavernous sinus<\/strong>, careful <strong>MRI surveillance<\/strong> may be preferred over immediate radiation if the remnant is stable and asymptomatic.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The final treatment decision is usually made by a <strong>multidisciplinary team<\/strong>, including a <strong>neurosurgeon<\/strong>, <strong>radiation oncologist<\/strong>, and <strong>neuroradiologist<\/strong>.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Planned subtotal resection followed by radiosurgery is more common in medial sphenoid wing meningiomas than in lateral tumors<\/strong>, because dense adherence to the <strong>optic nerve<\/strong>, <strong>carotid artery<\/strong>, or <strong>cavernous sinus<\/strong> may make complete removal unsafe.<\/p>\n\n\n\n<div style=\"border: 1px solid #ccc; border-radius: 12px; padding: 20px; margin-top: 40px; box-shadow: 0 2px 8px rgba(0,0,0,0.1); background-color: #f9f9f9;\"> \n  <h2 id=\"telehealth\" style=\"margin-top: 0; color: #004466;\">\n    Request Sphenoid Wing Meningioma Second Opinion \u2014 24-Hour Review (Priority Option Available Within Hours)\n  <\/h2>\n\n  <p>\n    Being told that an <strong>MRI has revealed a sphenoid wing meningioma<\/strong> often raises important questions:\n    Is the tumor dangerous?\n    Should it be monitored or surgically removed?\n    Is vision at risk?\n    Why do some specialists recommend partial removal while others suggest more aggressive surgery?\n    Is radiosurgery an appropriate alternative?\n    <br><br>\n    An independent neurosurgical second opinion may help clarify the <strong>urgency of treatment<\/strong>,\n    expected neurological and visual outcome, likelihood of tumor growth or recurrence, and the safest balance between\n    observation, surgical removal, and radiation therapy based on MRI findings, tumor size, skull base extension,\n    relationship to the <strong>optic nerve, cavernous sinus, orbit, and major skull base arteries<\/strong>,\n    surrounding brain edema, and the patient\u2019s overall neurological condition.\n  <\/p>\n\n  <ul style=\"padding-left: 0; margin-bottom: 20px; list-style: none;\">\n    <li style=\"position: relative; padding-left: 28px; margin: 8px 0;\">\n      <span style=\"position:absolute; left:0; top:0;\">\u2714<\/span>\n      Send a brief message describing your current symptoms and the key findings from your MRI or CT report\n    <\/li>\n    <li style=\"position: relative; padding-left: 28px; margin: 8px 0;\">\n      <span style=\"position:absolute; left:0; top:0;\">\u2714<\/span>\n      You will receive a reply within 24 hours explaining whether an online consultation is appropriate and which documentation is required\n    <\/li>\n    <li style=\"position: relative; padding-left: 28px; margin: 8px 0;\">\n      <span style=\"position:absolute; left:0; top:0;\">\u2714<\/span>\n      <strong>Priority cases:<\/strong> rapidly worsening vision, significant orbital or optic nerve compression, progressive neurological symptoms, proposed urgent surgery, or conflicting specialist recommendations \u2014 write PRIORITY in your first message\n    <\/li>\n    <li style=\"position: relative; padding-left: 28px; margin: 8px 0;\">\n      <span style=\"position:absolute; left:0; top:0;\">\u2714<\/span>\n      MRI images (DICOM format), radiology reports, and relevant documentation can be reviewed to assess tumor size, skull base involvement, surrounding brain edema, and possible treatment strategies\n    <\/li>\n    <li style=\"position: relative; padding-left: 28px; margin: 8px 0;\">\n      <span style=\"position:absolute; left:0; top:0;\">\u2714<\/span>\n      During consultation we explain whether observation, microsurgical removal, radiosurgery, or combined treatment is most appropriate \u2014 including expected neurological and visual risks and up to 10 days of follow-up clarification\n    <\/li>\n  <\/ul>\n\n  <div style=\"margin-bottom: 15px;\">\n    <div style=\"font-weight: bold;\">\n      Consultation fees typically range from $180\u2013250 depending on case complexity and documentation volume.\n    <\/div>\n    <div style=\"font-weight: bold;\">\n      Secure payment by credit card, PayPal invoice (USD), or bank transfer.\n    <\/div>\n    <div style=\"font-size: 14px; color: #333; margin-top: 4px;\">\n      This corresponds to typical international specialist telehealth neurosurgical second-opinion services.\n    <\/div>\n  <\/div>\n\n  <div style=\"display: flex; gap: 10px; flex-wrap: wrap;\">\n    <a href=\"https:\/\/wa.me\/381628534555\" style=\"background-color: #25D366; color: white; padding: 10px 16px; border-radius: 8px; text-decoration: none;\">\n      \ud83d\udcf1 WhatsApp Message\n    <\/a>\n    <a href=\"mailto:zkoja@yahoo.com\" style=\"background-color: #0073aa; color: white; padding: 10px 16px; border-radius: 8px; text-decoration: none;\">\n      \u2709 Email Us\n    <\/a>\n    <a href=\"https:\/\/m.me\/zeljko.kojadinovic.3\" style=\"background-color: #1877f2; color: white; padding: 10px 16px; border-radius: 8px; text-decoration: none;\">\n      \ud83d\udcac Messenger Chat\n    <\/a>\n  <\/div>\n<\/div>\n\n\n\n<h2 id=\"recurrence\" class=\"wp-block-heading\">Recurrence of Sphenoid Wing Meningiomas<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">The likelihood of recurrence depends on <strong>tumor grade<\/strong> and <strong>completeness of removal<\/strong>.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">\u2022 After complete removal of benign meningiomas, recurrence occurs in approximately <strong>5\u201310%<\/strong> of cases over <strong>10\u201315 years<\/strong><br>\u2022 After subtotal removal, recurrence rates may reach <strong>20\u201340%<\/strong><br>\u2022 Atypical meningiomas recur in approximately <strong>30\u201340%<\/strong> of cases<br>\u2022 Malignant meningiomas may recur in <strong>50\u201380%<\/strong> of patients<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Because recurrence may occur many years after treatment, <strong>long-term MRI follow-up is essential<\/strong>.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">When a sphenoid wing meningioma recurs, treatment decisions depend on several factors:<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">\u2022 <strong>tumor growth rate<\/strong><br>\u2022 <strong>tumor size<\/strong><br>\u2022 relationship to the <strong>optic nerve<\/strong>, <strong>carotid artery<\/strong>, <strong>cavernous sinus<\/strong>, and <strong>orbit<\/strong><br>\u2022 <strong>previous treatments<\/strong><br>\u2022 <strong>patient symptoms<\/strong><br>\u2022 <strong>histological grade<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Not all recurrences require immediate treatment. Some small stable recurrences can be monitored, while others require <strong>surgery<\/strong>, <strong>radiation<\/strong>, or <strong>both<\/strong>.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">Observation of Small Recurrences<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Small recurrent sphenoid wing meningiomas that show minimal or no growth may initially be managed with <strong>MRI surveillance<\/strong>.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Observation is most commonly chosen when:<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">\u2022 the recurrent tumor is <strong>small<\/strong><br>\u2022 the patient has <strong>no neurological or visual symptoms<\/strong><br>\u2022 imaging shows <strong>slow or stable growth<\/strong><br>\u2022 the recurrence is located in a <strong>higher-risk surgical area<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Follow-up usually involves <strong>MRI every 6\u201312 months<\/strong>.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">Repeat Surgery<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Surgical reoperation is considered when:<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">\u2022 the recurrent tumor causes <strong>neurological<\/strong>, <strong>visual<\/strong>, <strong>orbital<\/strong>, or <strong>seizure-related symptoms<\/strong><br>\u2022 imaging shows <strong>significant growth<\/strong><br>\u2022 the tumor is <strong>accessible for safe removal<\/strong><br>\u2022 mass effect on the brain or optic structures becomes <strong>clinically important<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Repeat surgery aims to remove the recurrent tumor and, when possible, its dural attachment.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">However, reoperation may be more technically demanding because:<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">\u2022 <strong>scar tissue<\/strong> from the previous surgery may be present<br>\u2022 arteries, optic structures, cranial nerves, or orbital tissues may already be <strong>displaced<\/strong><br>\u2022 previous skull base drilling or reconstruction may alter <strong>normal anatomy<\/strong><\/p>\n\n\n\n<h3 class=\"wp-block-heading\">Radiation Therapy for Recurrence<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Radiation therapy is frequently used for recurrent sphenoid wing meningiomas, particularly when complete reoperation is not feasible.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Radiation may be recommended when:<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">\u2022 <strong>residual tumor remains<\/strong> after surgery<br>\u2022 recurrence occurs after previous surgery<br>\u2022 the tumor lies in a <strong>surgically difficult skull base location<\/strong><br>\u2022 the tumor shows <strong>atypical or malignant histology<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Two main radiation approaches are used:<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">\u2022 <strong>fractionated radiotherapy<\/strong>, typically delivering <strong>50\u201354 Gy<\/strong><br>\u2022 <strong>stereotactic radiosurgery<\/strong>, usually delivering <strong>12\u201316 Gy<\/strong> in a single focused treatment<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">When recurrent tumor lies close to the <strong>optic nerve<\/strong> or <strong>chiasm<\/strong>, fractionated treatment is often safer than single-session radiosurgery.<\/p>\n\n\n\n<h2 id=\"treatment-by-tumor-grade\" class=\"wp-block-heading\">Treatment Strategy by Tumor Grade<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Management also depends strongly on the <strong>WHO tumor grade<\/strong>.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">\u2022 <strong>WHO grade I meningiomas.<\/strong> Recurrence may be managed with <strong>observation<\/strong>, <strong>repeat surgery<\/strong>, or <strong>radiosurgery<\/strong>, depending on tumor growth and symptoms.<br>\u2022 <strong>WHO grade II (atypical) meningiomas.<\/strong> These tumors recur more frequently. <strong>Postoperative radiotherapy<\/strong> is often recommended, particularly after incomplete tumor removal, although some patients may be managed with close MRI follow-up after complete resection.<br>\u2022 <strong>WHO grade III (malignant) meningiomas.<\/strong> These aggressive tumors typically require <strong>postoperative radiotherapy regardless of the completeness of surgical removal<\/strong>, together with close imaging follow-up.<\/p>\n\n\n\n<div style=\"background:#f4faff;border:1px solid #cce5ff;border-radius:10px;padding:18px;margin:28px 0;box-shadow:0 2px 6px rgba(0,0,0,0.05);line-height:1.45;\">\n\n  <h2 id=\"treatment-decision-summary\" style=\"color:#005c99;margin:0 0 10px 0;\">Treatment Decision Summary for Sphenoid Wing Meningioma<\/h2>\n\n  <p style=\"margin:6px 0;\">Treatment decisions for sphenoid wing meningioma usually follow several general principles.<\/p>\n\n  <h3 style=\"color:#005c99;margin:12px 0 4px 0;font-size:1.05em;\">1. Before treatment<\/h3>\n\n  <p style=\"margin:4px 0;\">If the tumor is small, causes no clear neurological or visual symptoms, and does not significantly compress the brain, optic pathways, or orbit, MRI monitoring is often the safest first step.<\/p>\n\n  <p style=\"margin:4px 0;\">If the tumor causes visual decline, double vision, eye protrusion (proptosis), seizures, progressive headaches, significant mass effect or edema, or shows documented growth on follow-up imaging, active treatment is more often recommended.<\/p>\n\n  <h3 style=\"color:#005c99;margin:12px 0 4px 0;font-size:1.05em;\">2. Choosing the main treatment<\/h3>\n\n  <p style=\"margin:4px 0;\">\nIn general, tumors smaller than about <strong>2.5\u20133 cm<\/strong> that demonstrate documented growth and are located at a safe distance from the <strong>optic nerve<\/strong> may be suitable for <strong>stereotactic radiosurgery (SRS)<\/strong>. Larger tumors, tumors causing significant <strong>brain compression<\/strong>, <strong>orbital involvement<\/strong>, or <strong>brain edema<\/strong>, or tumors closely related to the <strong>internal carotid artery<\/strong>, <strong>cavernous sinus<\/strong>, or major vessels usually require <strong>microsurgical removal through craniotomy<\/strong>. In many sphenoid wing meningiomas, the most common surgical approach is a <strong>pterional (frontotemporal) craniotomy<\/strong>, although the exposure may be modified depending on tumor extension. \n<strong>If the tumor is densely adherent to the optic nerve or other critical structures, complete removal may not be safe.<\/strong> In such cases, the tumor may be intentionally debulked and gently separated from the optic nerve to relieve compression and reduce surgical risk, and the remaining tumor may later be treated with <strong>radiosurgery or fractionated radiotherapy<\/strong>.\n<\/p>\n\n  <h3 style=\"color:#005c99;margin:12px 0 4px 0;font-size:1.05em;\">3. After surgery<\/h3>\n\n  <p style=\"margin:4px 0;\"><strong>WHO Grade I + complete removal:<\/strong> MRI follow-up is usually sufficient.<\/p>\n\n  <p style=\"margin:4px 0;\"><strong>WHO Grade I + residual tumor:<\/strong> follow-up or radiosurgery\/radiotherapy may be considered depending on tumor growth, residual size, and proximity to the optic nerve, cavernous sinus, or major arteries.<\/p>\n\n  <p style=\"margin:4px 0;\"><strong>WHO Grade II:<\/strong> postoperative radiotherapy is usually recommended after incomplete tumor removal. After complete resection, some patients may be managed with MRI follow-up or radiotherapy depending on recurrence risk.<\/p>\n\n  <p style=\"margin:4px 0;\"><strong>WHO Grade III:<\/strong> surgery is usually followed by radiotherapy regardless of the completeness of tumor removal, together with close imaging follow-up.<\/p>\n\n  <p style=\"margin:8px 0 0 0;\"><em>This is a simplified overview. In real clinical practice, treatment decisions also depend on tumor size, skull base extension, surrounding brain edema, relationship to the frontal and temporal lobes, optic nerve, cavernous sinus, orbit, and major skull base arteries, as well as patient age and overall neurological condition.<\/em><\/p>\n\n<\/div>\n\n\n\n<h2 id=\"long-term-monitoring\" class=\"wp-block-heading\">Long-Term Monitoring<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Because sphenoid wing meningiomas may recur many years after treatment, <strong>long-term follow-up is essential<\/strong>.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Typical surveillance includes:<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">\u2022 <strong>annual MRI<\/strong> for several years after treatment<br>\u2022 longer imaging intervals if the tumor remains <strong>stable<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Early detection of recurrence allows treatment before major <strong>neurological<\/strong>, <strong>visual<\/strong>, or <strong>orbital deterioration<\/strong> develops.<\/p>\n\n\n\n<h2 id=\"experimental-therapy\" class=\"wp-block-heading\">Experimental and Targeted Therapies<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Several medications have been studied for recurrent or progressive meningiomas when surgery and radiotherapy are no longer sufficient. These include <strong>bevacizumab<\/strong>, as well as drugs acting on molecular pathways such as <strong>AKT<\/strong> or <strong>SMO inhibitors<\/strong>. <strong>Somatostatin-receptor-based treatments<\/strong> such as <strong>octreotide<\/strong> and combinations including <strong>everolimus<\/strong> have also been investigated.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">However, current evidence remains limited, and <strong>surgery and radiation therapy remain the main treatments<\/strong> for most sphenoid wing meningiomas.<\/p>\n\n\n\n<h2 id=\"when-opinions-differ\" class=\"wp-block-heading\">When Expert Opinions May Differ<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">In many patients diagnosed with sphenoid wing meningioma, different specialists may recommend different treatment strategies. This is common in neurosurgery and does not necessarily mean that one opinion is correct while another is wrong.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Treatment decisions depend on multiple clinical factors, including:<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">\u2022 <strong>tumor size<\/strong><br>\u2022 <strong>tumor location<\/strong> and <strong>skull base extension<\/strong><br>\u2022 <strong>growth rate<\/strong> observed on MRI<br>\u2022 presence of <strong>surrounding edema<\/strong> or <strong>mass effect<\/strong><br>\u2022 <strong>patient age<\/strong> and overall health<br>\u2022 presence or absence of <strong>neurological symptoms<\/strong><br>\u2022 degree of <strong>visual risk<\/strong><br>\u2022 relationship of the tumor to the <strong>optic nerve<\/strong>, <strong>carotid artery<\/strong>, <strong>cavernous sinus<\/strong>, <strong>orbit<\/strong>, and <strong>major vessels<\/strong><br>\u2022 <strong>tumor grade<\/strong> if histological diagnosis is already known<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Because these factors interact in complex ways, reasonable specialists may arrive at different conclusions regarding the safest management strategy.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">Observation vs. Early Surgery<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">One of the most common differences in opinion occurs when a sphenoid wing meningioma is discovered incidentally on MRI and the patient has no obvious symptoms. Some specialists recommend <strong>active surveillance<\/strong>, particularly when the tumor is small and shows no signs of growth. Others may recommend <strong>earlier surgery<\/strong>, especially if the tumor is located in a position where further growth could later threaten the <strong>optic nerve<\/strong>, <strong>orbit<\/strong>, <strong>cavernous sinus<\/strong>, or <strong>major vessels<\/strong>.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">Differences in Surgical Strategy<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Even when surgery is recommended, surgeons may disagree about the optimal operative strategy. One surgeon may aim for <strong>maximal removal including the involved dura and abnormal bone<\/strong>, while another may prefer a <strong>more conservative removal<\/strong> if the tumor is densely adherent to the <strong>optic nerve<\/strong>, <strong>carotid artery<\/strong>, or <strong>cavernous sinus<\/strong>.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">These differences are especially common in <strong>medial sphenoid wing meningiomas<\/strong>, where complete removal may carry a greater risk of <strong>visual<\/strong> or <strong>cranial nerve injury<\/strong>. By contrast, <strong>lateral sphenoid wing tumors often allow a safer and more complete resection and may behave more like convexity meningiomas from the surgical point of view.<\/strong><\/p>\n\n\n\n<h3 class=\"wp-block-heading\">Surgery vs. Radiation Therapy<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Another area where opinions may differ involves the use of <strong>radiation therapy<\/strong>. Some specialists recommend <strong>surgery first<\/strong>, followed by radiation only if residual tumor remains. Others may recommend <strong>primary radiation<\/strong> in carefully selected small tumors or in patients with increased surgical risk.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">These differences usually reflect different risk assessments, particularly regarding <strong>vision<\/strong>, <strong>skull base anatomy<\/strong>, and <strong>long-term tumor control<\/strong>.<\/p>\n\n\n\n<h2 id=\"prognosis\" class=\"wp-block-heading\">How Prognosis Depends on Tumor Grade, Location, and Extent of Removal<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">The prognosis of sphenoid wing meningioma depends primarily on the <strong>biological grade<\/strong> of the tumor, its <strong>anatomical relationships<\/strong>, and the extent to which it can be <strong>safely removed<\/strong>.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">In most patients, sphenoid wing meningiomas are <strong>WHO Grade I tumors<\/strong>, which usually grow slowly and have a <strong>favorable long-term prognosis<\/strong> when treated appropriately.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Functional recovery after treatment varies depending on the structures that were compressed before surgery.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Vision.<\/strong> Visual disturbances may occur when the tumor compresses the <strong>optic nerve<\/strong> or <strong>optic canal<\/strong>. If visual loss is mild and compression is relieved early, visual improvement is observed in roughly <strong>50\u201370%<\/strong> of patients. When visual impairment has been severe or long-standing, recovery is less likely.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Eye movement and diplopia.<\/strong> When cranial nerves within the <strong>cavernous sinus<\/strong> or <strong>superior orbital fissure<\/strong> are affected, <strong>double vision<\/strong> or restricted eye movement may occur. Partial improvement is possible after treatment, but recovery is less predictable than for simple mass-effect symptoms.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Seizures and headaches.<\/strong> In patients with <strong>lateral tumors<\/strong> compressing the <strong>frontal<\/strong> or <strong>temporal lobe<\/strong>, headaches and seizures may improve substantially after decompression and tumor removal.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Tumor control is generally very good for benign tumors. When <strong>complete or near-complete removal<\/strong> is achieved, long-term tumor control is typically above <strong>85\u201390%<\/strong>. In cases where a small residual tumor remains, additional treatment with <strong>stereotactic radiosurgery<\/strong> or <strong>radiotherapy<\/strong> can often provide effective long-term control.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Overall prognosis is most favorable in patients with <strong>benign tumors<\/strong>, <strong>preserved vision<\/strong>, <strong>limited edema<\/strong>, and <strong>safe near-complete tumor removal<\/strong>. Prognosis is generally less favorable in <strong>higher-grade tumors<\/strong>, tumors involving the <strong>cavernous sinus<\/strong> or <strong>carotid artery<\/strong>, marked <strong>orbital<\/strong> or <strong>optic canal invasion<\/strong>, or cases where only limited tumor removal is possible.<\/p>\n\n\n\n<h2 id=\"can-this-tumor-be-dangerous\" class=\"wp-block-heading\"><strong>Can a Sphenoid Wing Meningioma Become Dangerous?<\/strong><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\"><br><strong>Yes \u2014 mainly because of its location, not only because of its biological grade.<\/strong> Most sphenoid wing meningiomas are slow-growing and not immediately life-threatening. However, some tumors \u2014 especially <strong>large medial lesions<\/strong> close to the <strong>optic nerve<\/strong>, <strong>carotid artery<\/strong>, <strong>cavernous sinus<\/strong>, or <strong>orbit<\/strong> \u2014 can become clinically serious because they may progressively threaten <strong>vision<\/strong>, <strong>eye movements<\/strong>, <strong>cranial nerve function<\/strong>, or cause major <strong>mass effect<\/strong> and <strong>brain edema<\/strong>. <strong>Lateral tumors<\/strong> may also become dangerous when they grow very large and compress the <strong>frontal<\/strong> or <strong>temporal lobe<\/strong>, but this is usually less typical than in complex medial skull base tumors.<\/p>\n\n\n\n<h2 id=\"faq-sphenoid-wing-meningioma\" style=\"margin-top: 14px;\">\nFrequently Asked Questions About Sphenoid Wing Meningioma\n<\/h2>\n\n<div class=\"faq-accordion\" style=\"margin:32px 0;\">\n  <style>\n    .faq-accordion details {\n      border: 1px solid #e3e8ef; border-radius: 10px; background:#f8fafc;\n      padding: 12px 16px; margin: 10px 0;\n    }\n    .faq-accordion summary {\n      list-style: none; cursor: pointer; font-weight: 700; color:#0b3a5e;\n      display:flex; justify-content:space-between; align-items:center; gap:12px;\n    }\n    .faq-accordion summary::-webkit-details-marker { display: none; }\n    .faq-accordion summary::after {\n      content: \"\uff0b\"; font-weight: 700; color:#0b3a5e; flex-shrink:0;\n      font-size:1.15em; line-height:1;\n    }\n    .faq-accordion details[open] summary::after { content: \"\u2212\"; }\n    .faq-accordion .answer { margin-top: 10px; color:#0f172a; line-height:1.6; }\n  <\/style>\n\n  <details>\n    <summary><h3 style=\"margin:0; font-size:1.05em; line-height:1.4;\">Can a sphenoid wing meningioma affect vision even when it is not very large?<\/h3><\/summary>\n    <div class=\"answer\">\n      Yes. A sphenoid wing meningioma can affect vision even when it is not very large if it grows medially toward the optic nerve, optic canal, or optic chiasm. In this location, even limited tumor growth may narrow the space around the visual pathway and produce progressive visual decline, blurred vision, or visual field defects. This is why tumor location is often more important than size alone. A lateral sphenoid wing meningioma may grow larger before causing major visual symptoms, while a medial tumor close to the optic nerve can become clinically important earlier. MRI with contrast, and sometimes CT to evaluate optic canal narrowing or bone thickening, helps determine whether vision is at risk.\n    <\/div>\n  <\/details>\n\n<details>\n  <summary><h3 style=\"margin:0; font-size:1.05em; line-height:1.4;\">Where is the sphenoid wing located?<\/h3><\/summary>\n  <div class=\"answer\">\n    The sphenoid wing is part of the skull base located behind the eye socket and beneath the frontal and temporal lobes. A sphenoid wing meningioma grows from the dura along this bony ridge. Its exact position matters because medial sphenoid wing tumors may lie close to the optic nerve, optic canal, cavernous sinus, carotid artery, and orbital apex, while lateral tumors are usually farther from these critical skull base structures. This anatomical difference strongly influences symptoms, surgical difficulty, and whether observation, surgery, radiosurgery, or radiotherapy is the safest treatment strategy.\n  <\/div>\n<\/details>\n\n  <details>\n    <summary><h3 style=\"margin:0; font-size:1.05em; line-height:1.4;\">Why can eye protrusion (proptosis) occur in sphenoid wing meningioma?<\/h3><\/summary>\n    <div class=\"answer\">\n      Eye protrusion, or proptosis, can occur in sphenoid wing meningioma when the tumor extends toward the orbit or causes thickening of the sphenoid bone, called hyperostosis. The sphenoid wing lies behind the eye socket, so tumor growth or abnormal bone expansion in this region can gradually reduce orbital space and push the eye forward. This change may be slow, and family members sometimes notice progressive eye prominence before the patient seeks evaluation. Proptosis is especially relevant when the tumor involves the orbit, orbital apex, or skull base bone. Treatment decisions depend on whether there is only cosmetic asymmetry, visual risk, optic nerve compression, cavernous sinus involvement, or broader skull base extension.\n    <\/div>\n  <\/details>\n\n  <details>\n    <summary><h3 style=\"margin:0; font-size:1.05em; line-height:1.4;\">Why are medial sphenoid wing meningiomas often more difficult to treat?<\/h3><\/summary>\n    <div class=\"answer\">\n      Medial sphenoid wing meningiomas are often more difficult to treat because they lie close to critical skull base structures. They may extend toward the optic nerve, optic canal, cavernous sinus, internal carotid artery, orbital apex, cranial nerves, and major blood vessels. These structures control vision, eye movement, facial sensation, and blood supply to the brain. Complete tumor removal may therefore carry a higher risk of visual loss, cranial nerve injury, or vascular injury. By contrast, lateral sphenoid wing meningiomas often behave more like convexity meningiomas and may allow safer, more complete removal. In medial tumors, the safest strategy may sometimes involve partial removal to decompress the optic nerve, followed by monitoring or radiation for residual tumor.\n    <\/div>\n  <\/details>\n\n  <details>\n    <summary><h3 style=\"margin:0; font-size:1.05em; line-height:1.4;\">How does sphenoid wing meningioma affect the optic nerve and optic canal?<\/h3><\/summary>\n    <div class=\"answer\">\n      Sphenoid wing meningioma can affect the optic nerve by compressing it directly or by extending into the optic canal, the bony tunnel through which the visual nerve passes. When the canal becomes narrowed by tumor or hyperostotic bone, the optic nerve may be compressed even if the visible tumor mass is not very large. This can cause progressive visual decline, visual field defects, or blurred vision. Importantly, visual worsening may sometimes occur even without obvious tumor enlargement on MRI if optic canal compression is present. In such cases, surgical decompression of the optic nerve may be recommended. The chance of visual recovery is better when compression is relieved early, before severe or long-standing damage develops.\n    <\/div>\n  <\/details>\n\n  <details>\n    <summary><h3 style=\"margin:0; font-size:1.05em; line-height:1.4;\">Can sphenoid wing meningioma compress the cavernous sinus or carotid artery?<\/h3><\/summary>\n    <div class=\"answer\">\n      Yes. A sphenoid wing meningioma, especially a medial tumor, may extend toward the cavernous sinus and internal carotid artery. The cavernous sinus is a critical skull base region containing cranial nerves that control eye movement and facial sensation, as well as important venous structures. The internal carotid artery is one of the main arteries supplying the brain. When the tumor is close to or adherent to these structures, surgery becomes more complex. Complete removal may not always be safe if the tumor surrounds or sticks firmly to nerves or vessels. This is one reason why some patients are advised to undergo subtotal removal, decompression, radiosurgery, radiotherapy, or long-term MRI monitoring rather than aggressive resection.\n    <\/div>\n  <\/details>\n\n  <details>\n    <summary><h3 style=\"margin:0; font-size:1.05em; line-height:1.4;\">Why may sphenoid wing meningioma remain unnoticed for years before diagnosis?<\/h3><\/summary>\n    <div class=\"answer\">\n      Sphenoid wing meningioma may remain unnoticed for years because most of these tumors grow slowly and initially produce few or nonspecific symptoms. A lateral tumor may cause mild headaches or seizures only after it irritates the frontal or temporal lobe. A medial tumor may gradually affect vision, eye movement, or orbital appearance, but these changes can develop slowly and may be attributed to eye disease or other causes. Some tumors are discovered incidentally during MRI or CT performed for unrelated reasons. Because meningiomas usually grow outside the brain and compress rather than invade tissue, symptoms often appear gradually. Diagnosis becomes more likely when visual decline, double vision, proptosis, seizures, or progressive headaches lead to imaging.\n    <\/div>\n  <\/details>\n\n  <details>\n    <summary><h3 style=\"margin:0; font-size:1.05em; line-height:1.4;\">Can headaches or seizures be caused by sphenoid wing meningioma?<\/h3><\/summary>\n    <div class=\"answer\">\n      Headaches or seizures can be caused by sphenoid wing meningioma, but the relationship must be assessed carefully. Headache is common in the general population and may be unrelated to a small, otherwise asymptomatic tumor. A sphenoid wing meningioma is more likely to cause headache when it becomes larger, produces significant brain edema, increases pressure, or compresses adjacent structures. Seizures are more likely when the tumor irritates the frontal or temporal lobe, especially in lateral sphenoid wing tumors. Medications may help control edema or seizures temporarily, but they do not eliminate the tumor itself. Treatment decisions depend on whether symptoms truly correlate with tumor location, edema, growth, and mass effect.\n    <\/div>\n  <\/details>\n\n  <details>\n    <summary><h3 style=\"margin:0; font-size:1.05em; line-height:1.4;\">Does every sphenoid wing meningioma require surgery?<\/h3><\/summary>\n    <div class=\"answer\">\n      No. Not every sphenoid wing meningioma requires surgery. Small tumors without clear neurological or visual symptoms, without documented growth, and without significant compression of the brain, optic pathways, orbit, or cavernous sinus may be monitored with periodic MRI. Observation is especially reasonable when there is little or no surrounding edema and when the patient is elderly or has medical conditions that increase surgical risk. Surgery becomes more likely when the tumor grows, causes visual decline, double vision, eye protrusion, seizures, progressive headaches, neurological deficits, brain edema, or significant mass effect. The decision is individualized because a small medial tumor near the optic canal may be more urgent than a larger lateral tumor in a safer location.\n    <\/div>\n  <\/details>\n\n  <details>\n    <summary><h3 style=\"margin:0; font-size:1.05em; line-height:1.4;\">When can sphenoid wing meningioma be monitored without treatment?<\/h3><\/summary>\n    <div class=\"answer\">\n      Sphenoid wing meningioma can be monitored without treatment when the tumor is small, causes no clear symptoms, shows little or no growth on MRI, has little or no surrounding brain edema, and does not significantly compress the optic nerve, optic canal, orbit, cavernous sinus, or brain. Follow-up usually involves MRI every 6\u201312 months initially. If the tumor remains stable, observation may continue. However, this location requires careful judgment. Even when tumor size appears stable, progressive visual decline may suggest optic nerve compression, particularly if the tumor extends into the optic canal. Monitoring becomes less appropriate if there is documented growth, increasing edema, visual risk, orbital involvement, seizures, or worsening neurological symptoms.\n    <\/div>\n  <\/details>\n\n  <details>\n    <summary><h3 style=\"margin:0; font-size:1.05em; line-height:1.4;\">How is treatment decision-making performed in sphenoid wing meningioma?<\/h3><\/summary>\n    <div class=\"answer\">\n      Treatment decision-making in sphenoid wing meningioma depends on tumor size, growth rate, symptoms, edema, and anatomical relationships. Doctors evaluate whether the tumor is lateral, middle, or medial; whether it compresses the optic nerve, optic canal, orbit, cavernous sinus, carotid artery, cranial nerves, frontal or temporal lobe; and whether the patient has visual decline, double vision, proptosis, seizures, headaches, or neurological deficits. Small stable tumors may be monitored. Small growing tumors safely away from the optic apparatus may be treated with stereotactic radiosurgery. Larger tumors, tumors with edema, orbital involvement, optic nerve compression, or close relationship to major vessels usually require microsurgical removal. The safest plan is individualized rather than automatic.\n    <\/div>\n  <\/details>\n\n  <details>\n    <summary><h3 style=\"margin:0; font-size:1.05em; line-height:1.4;\">When is radiosurgery appropriate for sphenoid wing meningioma?<\/h3><\/summary>\n    <div class=\"answer\">\n      Radiosurgery may be appropriate for sphenoid wing meningioma when the tumor is small, usually below about 2.5\u20133 cm, shows documented growth, does not cause significant brain compression, and is located at a safe distance from the optic nerve and optic chiasm. It may also be used for small residual tumor after surgery or for recurrence when reoperation is not ideal. Radiosurgery is usually not the best primary treatment for larger tumors with edema, orbital involvement, significant mass effect, or compression requiring decompression. In medial sphenoid wing meningiomas, proximity to the optic nerve, cavernous sinus, carotid artery, and cranial nerves often determines whether radiosurgery, fractionated radiotherapy, surgery, or combined treatment is safer.\n    <\/div>\n  <\/details>\n\n  <details>\n    <summary><h3 style=\"margin:0; font-size:1.05em; line-height:1.4;\">Why is fractionated radiotherapy sometimes preferred over radiosurgery in sphenoid wing meningioma?<\/h3><\/summary>\n    <div class=\"answer\">\n      Fractionated radiotherapy may be preferred over single-session radiosurgery in sphenoid wing meningioma when the tumor lies very close to the optic nerve, optic chiasm, cavernous sinus structures, or other critical tissues that tolerate only limited radiation exposure. In radiosurgery, the dose is delivered in one focused session, which can be unsafe near the visual pathways. Fractionated radiotherapy divides the total dose into smaller treatments over time, reducing the risk of radiation injury to vision. This approach may be considered when surgery is not possible, when residual tumor remains near sensitive structures, or when recurrent tumor continues to grow. The choice depends on tumor size, location, visual risk, prior treatment, and surgical feasibility.\n    <\/div>\n  <\/details>\n\n  <details>\n    <summary><h3 style=\"margin:0; font-size:1.05em; line-height:1.4;\">How is surgery for sphenoid wing meningioma performed?<\/h3><\/summary>\n    <div class=\"answer\">\n      Surgery for sphenoid wing meningioma is usually performed through a craniotomy, most commonly a pterional or frontotemporal approach. The scalp incision is placed in the hair-bearing area when possible, and a bone flap is created to expose the sphenoid ridge and adjacent skull base. The dura is opened, and the tumor is usually reduced internally first, often with an ultrasonic aspirator, to lower pressure and make dissection safer. The remaining tumor is then separated from the brain, blood vessels, optic apparatus, cranial nerves, and orbital structures under microsurgical magnification. The dural attachment is treated when safe, and abnormal hyperostotic bone may be drilled. The goals are decompression, tumor control, and preservation of vision and neurological function.\n    <\/div>\n  <\/details>\n\n  <details>\n    <summary><h3 style=\"margin:0; font-size:1.05em; line-height:1.4;\">Why may surgeons intentionally leave part of a sphenoid wing meningioma behind?<\/h3><\/summary>\n    <div class=\"answer\">\n      Surgeons may intentionally leave part of a sphenoid wing meningioma behind when complete removal would create an unacceptable risk of neurological or visual injury. This is more common in medial tumors that are densely adherent to the optic nerve, carotid artery, cavernous sinus, cranial nerves, or major skull base vessels. In these situations, aggressive resection may threaten vision, eye movement, facial sensation, or blood supply to the brain. The safer goal may be to debulk the tumor, decompress the optic pathways, reduce mass effect, and leave a small residual portion for follow-up or later radiosurgery or fractionated radiotherapy. This strategy is not failure; it is often a deliberate balance between tumor control and preservation of function.\n    <\/div>\n  <\/details>\n\n  <details>\n    <summary><h3 style=\"margin:0; font-size:1.05em; line-height:1.4;\">Can sphenoid wing meningioma surgery preserve vision and eye movement?<\/h3><\/summary>\n    <div class=\"answer\">\n      Sphenoid wing meningioma surgery can sometimes preserve or improve vision and eye movement, but the outcome depends on how long and how severely the optic nerve, optic canal, cavernous sinus, or cranial nerves have been compressed. If visual loss is mild and decompression is performed early, visual improvement is more likely. When visual impairment has been severe or long-standing, recovery is less predictable. Double vision or restricted eye movement may occur when cranial nerves in the cavernous sinus or superior orbital fissure are affected; improvement is possible but less certain than simple decompression symptoms. The surgical goal is to remove or reduce the tumor while protecting the optic nerve, carotid artery, cranial nerves, and brain function.\n    <\/div>\n  <\/details>\n\n<details>\n  <summary style=\"cursor:pointer;list-style:none;color:#000000 !important;\">\n    <h3 style=\"display:inline;font-size:1.05em;font-weight:700;margin:0;color:#000000 !important;\">\n      How do doctors determine whether headaches are actually caused by a sphenoid wing meningioma?\n    <\/h3>\n  <\/summary>\n\n  <div class=\"answer\">\n    <p>Headaches are more likely to be caused by a sphenoid wing meningioma when the tumor is large, produces frontal or temporal lobe compression, causes surrounding brain edema, or contributes to increased intracranial pressure. Doctors also consider whether the headache is new, progressively worsening, associated with visual symptoms, double vision, eye protrusion, seizures, cognitive change, or other neurological findings.<\/p>\n\n    <p>A small sphenoid wing meningioma discovered incidentally may not explain longstanding migraine, tension-type headache, or cervicogenic headache. Determining the relationship therefore requires careful review of the headache pattern, neurological and ophthalmological findings, MRI appearance, tumor size, edema, mass effect, orbital or dural involvement, and the presence of other symptoms caused by the tumor. Headache alone is usually not sufficient evidence that a small, otherwise asymptomatic tumor requires surgery.<\/p>\n  <\/div>\n<\/details>\n\n<details>\n  <summary style=\"cursor:pointer;list-style:none;color:#000000 !important;\">\n    <h3 style=\"display:inline;font-size:1.05em;font-weight:700;margin:0;color:#000000 !important;\">\n      How do doctors determine whether a sphenoid wing meningioma is truly causing seizures?\n    <\/h3>\n  <\/summary>\n\n  <div class=\"answer\">\n    <p>A sphenoid wing meningioma is more likely to be responsible for seizures when it is located laterally and directly compresses or irritates the adjacent frontal or temporal cortex, particularly when significant peritumoral brain edema is present. Doctors also assess whether the seizure pattern corresponds to the function of the affected brain region and whether the seizures began after the tumor became clinically relevant.<\/p>\n\n    <p>Evaluation usually includes a detailed seizure history, neurological examination, EEG findings, and careful review of MRI images. The relationship is more convincing when EEG abnormalities, seizure semiology, cortical compression, and edema correspond to the same anatomical region as the tumor. Other possible causes of epilepsy must also be excluded. When seizures remain uncontrolled or the relationship is uncertain, a structured epilepsy assessment may be required. More information is available on our <a href=\"https:\/\/neurohirurgija.in.rs\/en\/epilepsy-surgery-when-it-is-the-right-option\/\">epilepsy surgery page<\/a>.<\/p>\n  <\/div>\n<\/details>\n\n<details>\n  <summary style=\"cursor:pointer;list-style:none;color:#000000 !important;\">\n    <h3 style=\"display:inline;font-size:1.05em;font-weight:700;margin:0;color:#000000 !important;\">\n      What are the specific risks and complications of sphenoid wing meningioma surgery?\n    <\/h3>\n  <\/summary>\n\n  <div class=\"answer\">\n    <p>The risks depend mainly on whether the tumor is lateral, middle, or medial, as well as its size, surrounding brain edema, skull base and orbital extension, and relationship to the optic nerve, optic chiasm, internal carotid artery, middle and anterior cerebral arteries, cavernous sinus, cranial nerves, and frontal or temporal lobes. Possible complications include bleeding, postoperative hematoma, brain swelling, seizures, infection, cerebrospinal fluid leakage, meningitis, stroke, cerebral infarction, and new neurological deficits.<\/p>\n\n    <p>Injury to the optic nerve or optic chiasm may cause worsening vision or permanent visual loss. Injury to the internal carotid artery or nearby cerebral vessels may cause severe bleeding, cerebral ischemia, or stroke. Cavernous sinus involvement increases the risk of damage to cranial nerves III, IV, V1, V2, and VI, which may lead to double vision, ptosis, impaired eye movement, facial numbness, or facial pain. Orbital involvement may require bone removal or reconstruction and may not always fully correct proptosis. A small residual tumor may be intentionally left around the optic nerve, carotid artery, or cavernous sinus to avoid permanent injury. Residual or recurrent tumor may later require MRI monitoring, radiosurgery, radiotherapy, or further surgery. A broader explanation is available on our <a href=\"https:\/\/neurohirurgija.in.rs\/en\/craniotomy-brain-surgery-complications\/\">craniotomy and brain surgery complications page<\/a>.<\/p>\n  <\/div>\n<\/details>\n\n  <details>\n    <summary><h3 style=\"margin:0; font-size:1.05em; line-height:1.4;\">Why may specialists recommend different treatments for sphenoid wing meningioma?<\/h3><\/summary>\n    <div class=\"answer\">\n      Specialists may recommend different treatments for sphenoid wing meningioma because the safest plan depends on many interacting factors. One specialist may recommend observation if the tumor is small, stable, and asymptomatic. Another may recommend early surgery if the tumor threatens the optic nerve, orbit, cavernous sinus, or major vessels. Surgeons may also differ in how aggressively they would remove tumor, dura, or abnormal bone, especially when the tumor is adherent to the optic nerve, carotid artery, or cavernous sinus. Radiation may be recommended for small tumors, residual tumor, or recurrence when surgery carries higher risk. These differences usually reflect different risk assessments, not necessarily conflicting standards of care.\n    <\/div>\n  <\/details>\n\n  <details>\n    <summary><h3 style=\"margin:0; font-size:1.05em; line-height:1.4;\">Can sphenoid wing meningioma recur after surgery or radiation treatment?<\/h3><\/summary>\n    <div class=\"answer\">\n      Yes. Sphenoid wing meningioma can recur after surgery or radiation treatment, although the risk depends mainly on WHO grade and completeness of removal. Benign tumors that are completely removed have a lower recurrence risk, while subtotal removal, atypical meningioma, and malignant meningioma carry higher recurrence rates. Recurrence is also influenced by whether the dural attachment and involved bone can be treated safely. In sphenoid wing meningiomas, complete removal may be limited by the optic nerve, carotid artery, cavernous sinus, orbit, cranial nerves, or infiltrated skull base bone. Small stable recurrences may sometimes be monitored, while growing or symptomatic recurrences may require repeat surgery, radiosurgery, fractionated radiotherapy, or combined treatment.\n    <\/div>\n  <\/details>\n\n  <details>\n    <summary><h3 style=\"margin:0; font-size:1.05em; line-height:1.4;\">How does WHO grade influence prognosis in sphenoid wing meningioma?<\/h3><\/summary>\n    <div class=\"answer\">\n      WHO grade influences prognosis in sphenoid wing meningioma because it reflects the biological behavior of the tumor. Most sphenoid wing meningiomas are WHO Grade I, which usually means slow growth and favorable long-term prognosis when treatment is appropriate. WHO Grade II atypical tumors have increased cellular activity and a higher chance of recurrence. WHO Grade III malignant meningiomas are rare but more aggressive and usually require combined surgery and radiotherapy. However, grade is not the only factor. Prognosis also depends on tumor location, relationship to the optic nerve, carotid artery, cavernous sinus, orbit, brain edema, and whether safe complete or near-complete removal is possible. A benign tumor can still be clinically serious if it compresses critical structures.\n    <\/div>\n  <\/details>\n\n  <details>\n    <summary><h3 style=\"margin:0; font-size:1.05em; line-height:1.4;\">Can a sphenoid wing meningioma become dangerous despite being benign?<\/h3><\/summary>\n    <div class=\"answer\">\n      Yes. A sphenoid wing meningioma can become dangerous despite being benign because the risk often comes from location and compression, not only from tumor grade. Most are slow-growing and not immediately life-threatening, but large or medial tumors may progressively threaten vision, eye movements, cranial nerve function, or major skull base arteries. Tumors extending into the optic canal, orbit, cavernous sinus, or around the carotid artery can create serious treatment dilemmas. Lateral tumors may also become dangerous if they grow large enough to compress the frontal or temporal lobe, produce edema, seizures, or mass effect. Therefore, \u201cbenign\u201d does not always mean harmless; size, location, growth, symptoms, and compression determine clinical danger.\n    <\/div>\n  <\/details>\n\n  <details>\n    <summary><h3 style=\"margin:0; font-size:1.05em; line-height:1.4;\">Can an online second opinion help clarify treatment decisions for sphenoid wing meningioma?<\/h3><\/summary>\n    <div class=\"answer\">\n      Yes. An online second opinion can help clarify treatment decisions for sphenoid wing meningioma when MRI or CT has shown the tumor but the safest strategy is unclear. It is especially useful when opinions differ between monitoring, surgery, radiosurgery, or radiotherapy; when surgery is recommended but expected risks are uncertain; or when vision, eye movement, proptosis, seizures, headaches, or skull base extension raise concern. MRI images, reports, and medical documentation can be reviewed to assess tumor size, growth, edema, relationship to the optic nerve, cavernous sinus, orbit, carotid artery, and major vessels. The goal is to explain whether observation, microsurgical removal, radiation, or combined treatment is most appropriate.\n    <\/div>\n  <\/details>\n\n<\/div>\n\n\n\n<!-- Meningioma cluster mini-nav (place near bottom of each page) -->\n<nav aria-label=\"Meningioma cluster\" class=\"meningioma-mini\" style=\"margin:20px 0;font-size:12.5px;color:#555;background:#f7faff;border:1px solid #d9ecff;border-radius:8px;padding:10px 12px;\">\n  <div style=\"font-weight:600;color:#0a4d78;margin:0 0 6px 0\">Related meningioma pages<\/div>\n  <ul style=\"list-style:none;margin:0;padding:0;display:flex;flex-wrap:wrap;gap:10px 16px;\">\n    <li><a href=\"https:\/\/neurohirurgija.in.rs\/en\/meningiomas\/\">Meningiomas (hub)<\/a><\/li>\n    <li><a href=\"https:\/\/neurohirurgija.in.rs\/en\/convexity-meningioma\/\">Convexity meningioma<\/a><\/li>\n    <li><a href=\"https:\/\/neurohirurgija.in.rs\/en\/parasagittal-meningioma\/\">Parasagittal meningioma<\/a><\/li>\n    <li><a href=\"https:\/\/neurohirurgija.in.rs\/en\/olfactory-groove-meningioma\/\">Olfactory groove meningioma<\/a><\/li>\n    <li><a href=\"https:\/\/neurohirurgija.in.rs\/en\/sphenoid-wing-meningioma\/\">Sphenoid wing meningioma<\/a><\/li>\n  <\/ul>\n<\/nav>\n\n<script>\n(function () {\n  function norm(u){\n    try{\n      var p = new URL(u, location.origin).pathname.toLowerCase();\n      p = p.replace(\/\\\/+$\/,'') + '\/';               \/\/ trailing slash\n      p = decodeURI(p);                             \/\/ decode\n      return p;\n    }catch(e){ return ''; }\n  }\n\n  \/\/ use canonical if available, otherwise location\n  var canon = document.querySelector('link[rel=\"canonical\"]');\n  var here  = norm(canon ? canon.href : location.href);\n\n  \/\/ collapse slug variants\n  function collapse(p){\n    return p\n      .replace(\/(meningiomas)(-[a-z0-9-]+)?\\\/\/,'$1\/')\n      .replace(\/(convexity-meningioma)(-[a-z0-9-]+)?\\\/\/,'$1\/')\n      .replace(\/(parasagittal-meningioma)(-[a-z0-9-]+)?\\\/\/,'$1\/')\n      .replace(\/(olfactory-groove-meningioma)(-[a-z0-9-]+)?\\\/\/,'$1\/')\n      .replace(\/(sphenoid-wing-meningioma)(-[a-z0-9-]+)?\\\/\/,'$1\/');\n  }\n\n  var hereCollapsed = collapse(here);\n\n  document.querySelectorAll('nav.meningioma-mini a').forEach(function (a) {\n    var ap = norm(a.href);\n    var apCollapsed = collapse(ap);\n\n    if (ap === here || apCollapsed === hereCollapsed) {\n      var span = document.createElement('span');\n      span.textContent = a.textContent;\n      span.setAttribute('aria-current', 'page');\n      span.style.fontWeight = '600';\n      span.style.color = '#0a4d78';\n      a.replaceWith(span);\n    }\n  });\n})();\n<\/script>\n","protected":false},"excerpt":{"rendered":"<p>Author: Dr. Zeljko Kojadinovic, MD, PhD \u2014 Consultant Neurosurgeon Specialized Experience: 30 years of clinical expertise in neurosurgery. Last medically reviewed: March 08, 2026 Who This Sphenoid Wing Meningioma Page Is For This page is intended for patients in whom MRI or CT has revealed a sphenoid wing meningioma, a tumor arising from the meninges [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_seopress_titles_title":"Sphenoid Wing Meningioma \u2014 Symptoms, Surgery, Treatment & Prognosis","_seopress_titles_desc":"Sphenoid wing meningioma symptoms, vision problems, surgery, radiosurgery, and prognosis explained in a patient-friendly neurosurgical guide.","_seopress_robots_index":"","_seopress_robots_follow":"","_seopress_robots_imageindex":"","_seopress_robots_snippet":"","_seopress_robots_primary_cat":"","_seopress_robots_breadcrumbs":"","_seopress_robots_freeze_modified_date":"","_seopress_robots_custom_modified_date":"","_seopress_robots_canonical":"","_seopress_social_fb_title":"","_seopress_social_fb_desc":"","_seopress_social_fb_img":"","_seopress_social_fb_img_attachment_id":0,"_seopress_social_fb_img_width":0,"_seopress_social_fb_img_height":0,"_seopress_social_twitter_title":"","_seopress_social_twitter_desc":"","_seopress_social_twitter_img":"","_seopress_social_twitter_img_attachment_id":0,"_seopress_social_twitter_img_width":0,"_seopress_social_twitter_img_height":0,"_seopress_redirections_value":"","_seopress_redirections_enabled":"","_seopress_redirections_enabled_regex":"","_seopress_redirections_logged_status":"both","_seopress_redirections_param":"","_seopress_redirections_type":301,"_seopress_analysis_target_kw":"","_uf_show_specific_survey":0,"_uf_disable_surveys":false,"footnotes":""},"class_list":["post-12075","page","type-page","status-publish","hentry"],"blocksy_meta":[],"_links":{"self":[{"href":"https:\/\/neurohirurgija.in.rs\/en\/wp-json\/wp\/v2\/pages\/12075","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/neurohirurgija.in.rs\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/neurohirurgija.in.rs\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/neurohirurgija.in.rs\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/neurohirurgija.in.rs\/en\/wp-json\/wp\/v2\/comments?post=12075"}],"version-history":[{"count":45,"href":"https:\/\/neurohirurgija.in.rs\/en\/wp-json\/wp\/v2\/pages\/12075\/revisions"}],"predecessor-version":[{"id":15149,"href":"https:\/\/neurohirurgija.in.rs\/en\/wp-json\/wp\/v2\/pages\/12075\/revisions\/15149"}],"wp:attachment":[{"href":"https:\/\/neurohirurgija.in.rs\/en\/wp-json\/wp\/v2\/media?parent=12075"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}